What If Scientists Shared Their Reagents for Free?
Some researchers have decided to provide their products without financial compensation or expectations of authorship on resulting papers, prompting a flurry of new work.
What If Scientists Shared Their Reagents for Free?
What If Scientists Shared Their Reagents for Free?
Some researchers have decided to provide their products without financial compensation or expectations of authorship on resulting papers, prompting a flurry of new work.
Some researchers have decided to provide their products without financial compensation or expectations of authorship on resulting papers, prompting a flurry of new work.
As the pandemic has underscored the importance—and benefits—of communicating science to the general public, it’s also highlighted the challenges that researchers can face in speaking with journalists.
The now month-long invasion of Ukraine has resulted in changes in policies and severances of international scientific collaborations with Russian universities and researchers. The war has also precipitated a moral reckoning for many scientists in Russia.
A new wave of research is recruiting patients and other members of the public to serve as equal partners, bringing fresh perspectives to research on diseases and other conditions.
Percy Lavon Julian, a young, Black scientist working in Jim Crow America, gained international recognition after beating chemists at the University of Oxford in the race to synthesize the alkaloid physostigmine, used for decades as a treatment for glaucoma.
Hundreds of people turned up to show solidarity with three grad students suing the university over a professor’s alleged misconduct, while faculty who had previously spoken in the professor’s favor walk back their support.
The University of Washington researcher leveraged data from the Human Genome Project to identify genes underlying various health conditions and advance precision medicine.
More than a dozen current and former members of the White House Office of Science and Technology Policy have shared details of alleged mistreatment, prompting President Biden’s top scientist to issue a formal apology.
Multiple prestigious US biomedical research awards have rarely or never been granted to a scientist with Asian ancestry, illustrating racial bias within American research societies and institutions, a researcher argues.
COVID-19 has thrown science and scientists into the spotlight. Some have accepted the challenge, amassing hundreds of thousands of followers and using the ongoing pandemic as a “teachable moment.”
Postdoctoral fellows faced challenges before COVID-19 changed the way academia functions, and these early career scientists report that things have only gotten harder.
In a statement issued by UK Research and Innovation, stem cell biologist Fiona Watt said she was devastated to learn of the impact of her actions and behavior on colleagues.
Richard Sever and John Inglis | Nov 11, 2021 | 3 min read
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
Scientists face the ramifications of the country’s departure from the European Union, from delays in laboratory supplies to difficulties hiring international students and faculty.
Graduate students planned a three-day-long strike to demand fair pay, union security, and improved protections against sexual harassment and discrimination. If an agreement isn’t met, the union says they may strike longer, potentially disrupting university research.
An analysis finds that reviewers are more likely to choose to be de-anonymized when their reviews are positive, suggesting instituting a fully open process might discourage negative feedback.